Submitted by Anonymous (not verified) on 16 January 2026 - 15:10
Human medicines European public assessment report (EPAR): Xospata, gilteritinib, Date of authorisation: 24/10/2019, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Xospata, gilteritinib, Date of authorisation: 24/10/2019, Revision: 8, Status: Authorised